ELU-4-EA431B-1
Search studies
204869 Phase 2a/b in Ulcerative Colitis
204869 Phase 2a/b in Ulcerative Colitis
Types
Clinical Trial Ncit:c71104
ELU-4-907C53-1
ELU-4-54A576-1
LUCENT-1 (NCT 03518086)
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Types
Clinical Trial Ncit:c71104
ELU-4-58F581-1
Pfizer (NCT02958865)
The Pfizer UC dataset represents baseline, placebo and treatment (PF-06700841) subject and sample-level data extracted from a phase 2 study in moderate to severe ulcerative colitis.
Types
Clinical Trial Ncit:c71104
Nct02958865
ELU-4-B16B4B-1